The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle

Glioblastoma and Other Malignant Gliomas

Omuro, A. M. P. (2013) · JAMA · doi:10.1001/jama.2013.280319 · Cited by 2,308 · see citing works

Multicellular tumor spheroids: An underestimated tool is catching up again

Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674 · see citing works

Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies

Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597 · see citing works

Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor

Wiley, D. T., Webster, P. C., Gale, A., & Davis, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307152110 · Cited by 521 · see citing works

Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment

El‐Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 466 · see citing works

Current concepts and management of glioblastoma

Preusser, M., de Ribaupierre, S., Wöehrer, A., Erridge, S., Hegi, M. E., Weller, M., & Stupp, R. (2011) · Annals of Neurology · doi:10.1002/ana.22425 · Cited by 457 · see citing works

Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics

Gutteridge, R. E. A., Ndiaye, M. A., Liu, X., & Ahmad, N. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0897 · Cited by 406 · see citing works

Enhanced Gene Delivery and siRNA Silencing by Gold Nanoparticles Coated with Charge-Reversal Polyelectrolyte

Guo, S., Huang, Y., Jiang, Q., et al. (2010) · ACS Nano · doi:10.1021/nn101638u · Cited by 403 · see citing works

Prospects of immune checkpoint modulators in the treatment of glioblastoma

Preusser, M., Lim, M. K., Hafler, D. A., Reardon, D. A., & Sampson, J. H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.139 · Cited by 382 · see citing works

Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles

Gao, H., Qian, J., Cao, S., Yang, Z. H., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280 · see citing works

Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors

Dixit, S. K., Novak, T., Miller, K., Zhu, Y., Kenney, M. E., & Broome, A. (2014) · Nanoscale · doi:10.1039/c4nr04853a · Cited by 262 · see citing works

Glioma targeting and blood–brain barrier penetration by dual-targeting doxorubincin liposomes

Gao, J., Lv, Q., Li, L.-M., Tang, X.-J., Li, F., Hu, Y., & Han, M. Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.097 · Cited by 224 · see citing works

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

Cloughesy, T. F., Landolfi, J. C., Hogan, D. J., Bloomfield, S. M., Carter, B. S., Chen, C. C., Elder, J. B., Kalkanis, S. N., Kesari, S., Lai, A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9784 · Cited by 195 · see citing works

Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2 + Breast Cancer Growth and Metastasis

Yao, Y., Sun, T., Huang, S., Dou, S., Lin, L., Chen, J.-N., Ruan, J.-B., Mao, C., Yu, F., Zeng, M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003601 · Cited by 189 · see citing works

Glioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxel

Hu, Q., Gao, X., Gu, G., Kang, T., Tu, Y., Liu, Z., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.025 · Cited by 174 · see citing works

Synergistic Dual-Ligand Doxorubicin Liposomes Improve Targeting and Therapeutic Efficacy of Brain Glioma in Animals

Zong, T., Mei, L., Gao, H., Cai, W., Zhu, P., Shi, K., Chen, J., Wang, Y., Gao, F., & He, Q. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500057n · Cited by 160 · see citing works

Optical Imaging and Magnetic Field Targeting of Magnetic Nanoparticles in Tumors

Foy, S. P., Manthe, R. L., Foy, S. T., Dimitrijevic, S., Krishnamurthy, N., & Labhasetwar, V. D. (2010) · ACS Nano · doi:10.1021/nn101427t · Cited by 149 · see citing works

Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex

Kang, T., Jiang, M., Jiang, D., Feng, X., Yao, J., Song, Q., Chen, H., Gao, X., & Chen, J. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00222 · Cited by 139 · see citing works

Challenges and opportunities for siRNA-based cancer treatment

Wang, T., Shigdar, S. L., Shamaileh, H. A., Gantier, M. P., Yin, W., Xiang, D., Wang, L., Zhou, S.-F., Hou, Y., Wang, P., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.045 · Cited by 123 · see citing works

Paracellular Barrier and Tight Junction Protein Expression in the Immortalized Brain Endothelial Cell Lines bEND.3, bEND.5 and Mouse Brain Endothelial Cell 4

Watanabe, T., Dohgu, S., Takata, F., Nishioku, T., Nakashima, A., Futagami, K., Yamauchi, A., & Kataoka, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00915 · Cited by 115 · see citing works

Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment

Gao, H., Yang, Z. H., Cao, S., Xiong, Y., Zhang, S., Pang, Z., & Jiang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.076 · Cited by 93 · see citing works

Curcumin induces G2/M cell cycle arrest and apoptosis of head and neck squamous cell carcinomain vitroandin vivothrough ATM/Chk2/p53-dependent pathway

Hu, A., Huang, J., Zhang, J.-F., Dai, W.-J., Li, R., Lu, Z., Duan, J., Li, J., Chen, X.-P., Fan, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17096 · Cited by 89 · see citing works

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo

Signore, M., Pelacchi, F., Martino, S. D., Runci, D., Biffoni, M., Giannetti, S., Morgante, L., de Majo, M., Petricoin, E., Stancato, L. F., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.188 · Cited by 82 · see citing works

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells

Harris, P. S., Venkataraman, S., Alimova, I. N., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-80 · Cited by 82 · see citing works

Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis

Wang, B., Lv, L., Wang, Z., Zhao, Y., Wu, L. H., Fang, X., Xu, Q., & Xin, H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.068 · Cited by 78 · see citing works

Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas

Zhang, L., Kundu, S., Feenstra, T., Li, X., Jin, C., Laaniste, L., Hassan, T. E. A. E., Ohlin, K. E., Yu, D., Olofsson, T., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa1690 · Cited by 63 · see citing works

Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposome

Lv, Q., Li, L., Han, M. Y., Tang, X.-J., Yao, J.-N., Ying, X., Li, F., & Gao, J.-Q. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.025 · Cited by 61 · see citing works

Prediction of clinical outcome in glioblastoma using a biologically relevant nine‐microRNA signature

Hayes, J. L., Thygesen, H. H., Tumilson, C. A., Droop, A., Boissinot, M., Hughes, T. A., Westhead, D. R., Alder, J. E., Shaw, L., Short, S. C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.004 · Cited by 61 · see citing works

Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer

McCarroll, J. A., Dwarte, T. M., Baigude, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2664 · Cited by 60 · see citing works

Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma

Cheng, M.-W., Bing-chan, W., Weng, Z.-Q., & Zhu, X.-W. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.09.004 · Cited by 41 · see citing works

Positively and negatively surface-charged chondroitin sulfate-trimethylchitosan nanoparticles as protein carriers

Young, J., Chen, C.-C., Chen, Y.-C., et al. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.10.095 · Cited by 36 · see citing works

Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma

Amani, V. M., Prince, E. W., Alimova, I. N., Balakrishnan, I., Birks, D. K., Donson, A. M., Harris, P. S., Levy, J. M. M., Handler, M. H., Foreman, N. K., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2690-6 · Cited by 35 · see citing works

Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer

Mu, J., Hui, T., Shao, B., Li, L., Du, Z., Lu, L., Ye, L., Li, S., Li, Q., Xiao, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17055 · Cited by 35 · see citing works

Energetics of ligand-receptor binding affinity on endothelial cells: An in vitro model

Fotticchia, I., Guarnieri, D., Fotticchia, T., Falanga, A. P., Vecchione, R., Giancola, C., & Netti, P. A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.018 · Cited by 13 · see citing works

Protein-bound P-cresol inhibits human umbilical vein endothelial cell proliferation by inducing cell cycle arrest at G0/G1.

Li, L., Li, J., Li, X., & Fa-huan, Y. (2017) · PubMed Central · Cited by 13 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

Nanoparticle crossing of blood-brain barrier: A road to new therapeutic approaches to central nervous system diseases

Ceña, V., & Játiva, P. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0139 · Cited by 232 · see citing works

Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier

Teleanu, R. I., Preda, M. D., Niculescu, A.-G., Vladâcenco, O., Radu, C. I., Grumezescu, A. M., & Teleanu, D. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050987 · Cited by 200 · see citing works

Species specificity of iron delivery in hybridomas

Ill, C. R., Brehm, T., Lydersen, B. K., et al. (1988) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02628492 · Cited by 11 · see citing works

Commentary: Mutations of Transferrin Receptor 2 (Trf-2) and Iron Storage Disease

Beutler, E. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0383 · Cited by 2 · see citing works

Lymphocyte Proliferation Is Controlled by both Iron Availability and Regulation of Iron Uptake Pathways

Seligman, P. A., Kovár̆, J., & Gelfand, E. W. (2008) · Pathobiology · doi:10.1159/000163692 · Cited by 68 · see citing works

Transferrin receptor 2: a new molecule in iron metabolism

Trinder, D., & Baker, E. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00258-3 · Cited by 94 · see citing works

Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells

McGregor, S. J., Díaz, M. N., Oria, R., et al. (1990) · Biochemical Journal · doi:10.1042/bj2720377 · Cited by 52 · see citing works